Large-scale testing (Phase 3)Study completedNCT02799082
What this trial is testing
Evaluation of Efficacy and Safety of BF-200 ALA Used With Photodynamic Therapy in Patients With Actinic Keratosis.
Who this might be right for
Actinic Keratosis
Biofrontera Bioscience GmbH 122